help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hajjar, D. P.
Right arrow Articles by Fabricant, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hajjar, D. P.
Right arrow Articles by Fabricant, J.

American Journal of Pathology, Vol 122, 62-70, Copyright © 1986 by American Society for Investigative Pathology


REGULAR ARTICLES

Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation

DP Hajjar, CG Fabricant, CR Minick and J Fabricant

Infection of normocholesterolemic, specific-pathogen-free chickens with Marek's disease herpesvirus (MDV) has been shown histologically to lead to chronic atherosclerosis like that in humans. The development of herpesvirus-induced atherosclerosis in vivo and the presence of specific Marek's antigen within aortic cells suggested that MDV infection may modify lipid metabolism and lead to significant lipid accumulation. Experiments reported herein were designed to determine the types and quantity of lipid present in aortas from MDV-infected and uninfected chickens between 2 and 8 months of age following infection and assess one possible mechanism of lipid accumulation by evaluating the effect of MDV infection on aortic cholesterol and cholesteryl ester (CE) metabolism. Chromatographic-fluorometric analyses indicated that at 4 and 8 months of age after MDV inoculation, MDV-infected animals had a significant (P less than 0.05) two-fold to threefold increase in total aortic lipid accumulation characterized by significant increases in cholesterol, CE, triacylglycerol, and phospholipid as compared with aortas from uninfected animals. At 8 months of age, similar increases in aortic lipid accumulation were observed in MDV-infected animals as compared with those animals vaccinated with turkey herpesvirus and later challenged with MDV. CE synthetic activity was increased significantly by 50% at 4 months of age in the MDV-infected group as compared with the uninfected group, which could explain the initial increase in CE accumulation. By 8 months of age, the authors also observed a twofold increase in CE synthetic activity and a 30% and 80% reduction in lysosomal and cytoplasmic CE hydrolytic activities, respectively, in aortas of MDV-infected chickens as compared to controls. Moreover, infection with MDV blocked the activation of cytoplasmic CE hydrolytic activity by dibutyryl cyclic AMP or exogenous cyclic AMP-dependent protein kinase. Taken together, these results suggest that lipid accretion in aortas of MDV-infected chickens results, in part, from alterations in cholesterol/CE metabolism during early stages of the disease. These findings support the hypothesis that human atherosclerosis may result from specific herpesvirus infection which can alter lipid metabolism and lead to lipid accretion.


This article has been cited by other articles:


Home page
Annals of Clinical & Laboratory ScienceHome page
M. K. Froberg
CMV Escapes!
Ann. Clin. Lab. Sci., April 1, 2004; 34(2): 123 - 130.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. George, S. Greenberg, I. Barshack, M. Singh, S. Pri-Chen, S. Laniado, and G. Keren
Accelerated intimal thickening in carotid arteries of balloon-injured rats after immunization against heat shock protein 70
J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1564 - 1569.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Guetta, E. M Scarpati, and P. E DiCorleto
Effect of cytomegalovirus immediate early gene products on endothelial cell gene activity
Cardiovasc Res, June 1, 2001; 50(3): 538 - 546.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
M. K. Froberg, N. Seacotte, and E. Dahlberg
Cytomegalovirus Seropositivity and Serum Total Cholesterol Levels in Young Patients
Ann. Clin. Lab. Sci., April 1, 2001; 31(2): 157 - 161.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. L. Afonso, E. R. Tulman, Z. Lu, L. Zsak, D. L. Rock, and G. F. Kutish
The Genome of Turkey Herpesvirus
J. Virol., January 15, 2001; 75(2): 971 - 978.
[Abstract] [Full Text]


Home page
J. Virol.Home page
E. R. Tulman, C. L. Afonso, Z. Lu, L. Zsak, D. L. Rock, and G. F. Kutish
The Genome of a Very Virulent Marek's Disease Virus
J. Virol., September 1, 2000; 74(17): 7980 - 7988.
[Abstract] [Full Text]


Home page
CirculationHome page
Q. Xu, G. Schett, H. Perschinka, M. Mayr, G. Egger, F. Oberhollenzer, J. Willeit, S. Kiechl, and G. Wick
Serum Soluble Heat Shock Protein 60 Is Elevated in Subjects With Atherosclerosis in a General Population
Circulation, July 4, 2000; 102(1): 14 - 20.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. E. Epstein, J. Zhu, M. S. Burnett, Y. F. Zhou, G. Vercellotti, and D. Hajjar
Infection and Atherosclerosis : Potential Roles of Pathogen Burden and Molecular Mimicry
Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1417 - 1420.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Q. Xu, S. Kiechl, M. Mayr, B. Metzler, G. Egger, F. Oberhollenzer, J. Willeit, and G. Wick
Association of Serum Antibodies to Heat-Shock Protein 65 With Carotid Atherosclerosis : Clinical Significance Determined in a Follow-Up Study
Circulation, September 14, 1999; 100(11): 1169 - 1174.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. Ross
Atherosclerosis -- An Inflammatory Disease
N. Engl. J. Med., January 14, 1999; 340(2): 115 - 126.
[Full Text] [PDF]


Home page
CVIHome page
A. Tiran, R. A. Tio, E. Oostenveld, M. C. Harmsen, B. Tiran, P. Den Heijer, S. H. J. Monnink, M. M. Wilders-Truschnig, and T. H. The
Humoral Immune Response to Human Cytomegalovirus in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty
Clin. Vaccine Immunol., January 1, 1999; 6(1): 45 - 49.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. C. Nicholson and D. P. Hajjar
Herpesviruses in Atherosclerosis and Thrombosis : Etiologic Agents or Ubiquitous Bystanders?
Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 339 - 348.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Libby, D. Egan, and S. Skarlatos
Roles of Infectious Agents in Atherosclerosis and Restenosis: An Assessment of the Evidence and Need for Future Research
Circulation, December 2, 1997; 96(11): 4095 - 4103.
[Full Text]


Home page
Circ. Res.Home page
E. Guetta, V. Guetta, T. Shibutani, and S. E. Epstein
Monocytes Harboring Cytomegalovirus: Interactions With Endothelial Cells, Smooth Muscle Cells, and Oxidized Low-Density Lipoprotein : Possible Mechanisms for Activating Virus Delivered by Monocytes to Sites of Vascular Injury
Circ. Res., July 19, 1997; 81(1): 8 - 16.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
M. K. Froberg, A. Adams, N. Seacotte, J. Parker-Thornburg, and P. Kolattukudy
Cytomegalovirus Infection Accelerates Inflammation in Vascular Tissue Overexpressing Monocyte Chemoattractant Protein-1
Circ. Res., December 7, 2001; 89(12): 1224 - 1230.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Society for Investigative Pathology.